Onyx sues Bayer for rights to Nexavar spinoff - Pittsburgh Business Times:

http://financeservicesnews.com/oases-in-the-office.htm
Fluoro-sorafenib — a compound with the same chemical structure as except that a single fluorine atom is substitutedr for a hydrogenatom — was discovered durinv joint research between Onyx (NASDAQ: and Bayer, the company said in the suit filer in U.S. District Court for the Northern District of The compound, Onyx claimed in the suit against and Bayer AG, is jointlyy owned under the Onyx-Bayer 1994 collaboration agreement. Discussionsw with Bayer about Onyx’s rights to fluoro-sorafenib were not Onyx said. Nexavar, also known as sells for about $5,000 in the Uniteds States.
It is approved against liver cancef and advanced kidney cancer but has been studieffor non-small cell lung cancer, melanoma, breastf cancer and other cancers. Most Nexavar failed a late-stage trial to treag a form of melanoma. Nexavar registerecd net sales worldwideof $178 million in the first quarter, and Onyx recentlyt said net sales for the full year should be $850 milliojn to $875 million. The Onyx-Bayetr partnership has been one of thebiopharmaceutical industry’ss longest and most successful, and Onyx stressed in a press releases Sunday that it continues to work with Bayefr in the development and commercialization of Nexavar.
The companiez later this month will present data at the American Societyt for Clinical Oncology annual meetingin Orlando, from Nexavar studies in hepatocellular carcinoma, renalk cell carcinoma, thyroid cancer, lung cancer, acute myeloid leukemia and gastric cancer. Onyx and Bayeer split development costs worldwide except in Japan where Bayer is responsible for alldevelopmenyt costs, and Bayer books Nexavar revenue. Outside the United Statess and Japan, Bayer has exclusive marketintg rightsto Nexavar, which is a registered trademark of Bayer HealthCare Pharmaceuticals, and sharesw profits with Onyx 50-50.
“Against that background, we are disappointe that we could not resolve this matter and believwe this complaint is necessary to protectt our rights and the rights of our shareholderse under the collaboration Greg Giotta, vice president and chief legakl counsel of Onyx, said in a preparef statement. Leverkusen-based Bayer AG's U.S. headquarters are based in Robinson as well asBayer Corp.' MaterialSciences division.